Abstract Topics

Abstract Topics
  • Addressing the Global CV Risk Factors in Pre-Disease and in Disease
  • Arterial Properties, Central Blood Pressure and Augmentation Index in Pre-Disease and Disease in Patients with Cardiometabolic Syndrome
  • Arterial Properties, Evaluation and Treatment in Metabolic Syndrome
  • Benefits of Achieving Optimal Risk Factors Level – When, How and with What?
  • Cardiac Markers of Pre-Clinical Disease in Metabolic Syndrome Patients
  • Cardiometabolic Syndrome in Children
  • Children and Adolescents: PreHypertension and Metabolic Syndrome, Progression of Risk and Diagnosis of Disease
  • Effect of Pre-Disease Risk Factors in Patients with the Metabolic Syndrome on Morbidity and Mortality
  • Gestational Prehypertension and Gestational Hypertension
  • Metabolic Syndrome and Vitamin D
  • Prediabetes – Mechanisms, Diagnosis and Management
  • PreHypertension and Metabolic Syndrome in Different Populations – Epidemiologic Aspects
  • PreHypertension, Hypertension and Renal Denervation
  • PreHypertension, Prediabetes and Dyslipidemia – Estimation of Risk and Therapeutic Approach
  • Pre-Levels of CV Risk Factors – Boosting Risk of Events and Deciding Who Should be Treated
  • The Heart, the Brain and the Kidney in Pre-Disease and the Metabolic Syndrome
  • Total Cardiovascular Risk Evaluation and Management
  • Which Elderly Patients with Pre-Disease should be Considered for Medical Treatment